vs
ICU MEDICAL INC（ICUI）与LCI INDUSTRIES（LCII）财务数据对比。点击上方公司名可切换其他公司
LCI INDUSTRIES的季度营收约是ICU MEDICAL INC的1.7倍（$932.7M vs $540.7M），LCI INDUSTRIES净利率更高（2.0% vs -2.9%，领先4.9%），LCI INDUSTRIES同比增速更快（16.1% vs -14.1%），LCI INDUSTRIES自由现金流更多（$64.3M vs $36.0M），过去两年LCI INDUSTRIES的营收复合增速更高（-1.8% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
拉奇核心工业有限公司前身为巴基斯坦帝国化学工业公司，是一家总部位于卡拉奇的巴基斯坦综合性企业集团，业务覆盖聚酯、医药、农用化学品、纯碱及兽药等多品类产品的研发生产，在巴基斯坦本土工业领域拥有重要市场地位。
ICUI vs LCII — 直观对比
营收规模更大
LCII
是对方的1.7倍
$540.7M
营收增速更快
LCII
高出30.3%
-14.1%
净利率更高
LCII
高出4.9%
-2.9%
自由现金流更多
LCII
多$28.3M
$36.0M
两年增速更快
LCII
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $932.7M |
| 净利润 | $-15.7M | $18.7M |
| 毛利率 | 37.5% | 22.1% |
| 营业利润率 | 1.0% | 3.8% |
| 净利率 | -2.9% | 2.0% |
| 营收同比 | -14.1% | 16.1% |
| 净利润同比 | 34.0% | 95.7% |
| 每股收益（稀释后） | $-0.63 | $0.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUILCII
| Q4 25 | $540.7M | $932.7M | ||
| Q3 25 | $537.0M | $1.0B | ||
| Q2 25 | $548.9M | $1.1B | ||
| Q1 25 | $604.7M | $1.0B | ||
| Q4 24 | $629.8M | $803.1M | ||
| Q3 24 | $589.1M | $915.5M | ||
| Q2 24 | $596.5M | $1.1B | ||
| Q1 24 | $566.7M | $968.0M |
净利润ICUILCII
| Q4 25 | $-15.7M | $18.7M | ||
| Q3 25 | $-3.4M | $62.5M | ||
| Q2 25 | $35.3M | $57.6M | ||
| Q1 25 | $-15.5M | $49.4M | ||
| Q4 24 | $-23.8M | $9.5M | ||
| Q3 24 | $-33.0M | $35.6M | ||
| Q2 24 | $-21.4M | $61.2M | ||
| Q1 24 | $-39.5M | $36.5M |
毛利率ICUILCII
| Q4 25 | 37.5% | 22.1% | ||
| Q3 25 | 37.4% | 24.4% | ||
| Q2 25 | 37.9% | 24.4% | ||
| Q1 25 | 34.7% | 24.1% | ||
| Q4 24 | 36.1% | 21.1% | ||
| Q3 24 | 34.8% | 24.0% | ||
| Q2 24 | 34.8% | 25.3% | ||
| Q1 24 | 32.7% | 23.1% |
营业利润率ICUILCII
| Q4 25 | 1.0% | 3.8% | ||
| Q3 25 | 2.6% | 7.3% | ||
| Q2 25 | 1.9% | 7.9% | ||
| Q1 25 | 2.1% | 7.8% | ||
| Q4 24 | 6.0% | 2.0% | ||
| Q3 24 | 1.4% | 5.9% | ||
| Q2 24 | 1.3% | 8.6% | ||
| Q1 24 | -1.9% | 6.0% |
净利率ICUILCII
| Q4 25 | -2.9% | 2.0% | ||
| Q3 25 | -0.6% | 6.0% | ||
| Q2 25 | 6.4% | 5.2% | ||
| Q1 25 | -2.6% | 4.7% | ||
| Q4 24 | -3.8% | 1.2% | ||
| Q3 24 | -5.6% | 3.9% | ||
| Q2 24 | -3.6% | 5.8% | ||
| Q1 24 | -7.0% | 3.8% |
每股收益（稀释后）ICUILCII
| Q4 25 | $-0.63 | $0.79 | ||
| Q3 25 | $-0.14 | $2.55 | ||
| Q2 25 | $1.43 | $2.29 | ||
| Q1 25 | $-0.63 | $1.94 | ||
| Q4 24 | $-0.97 | $0.37 | ||
| Q3 24 | $-1.35 | $1.39 | ||
| Q2 24 | $-0.88 | $2.40 | ||
| Q1 24 | $-1.63 | $1.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $222.6M |
| 总债务越低越好 | — | $945.2M |
| 股东权益账面价值 | $2.1B | $1.4B |
| 总资产 | $4.1B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资ICUILCII
| Q4 25 | — | $222.6M | ||
| Q3 25 | — | $199.7M | ||
| Q2 25 | — | $191.9M | ||
| Q1 25 | — | $231.2M | ||
| Q4 24 | $308.6M | $165.8M | ||
| Q3 24 | $312.5M | $161.2M | ||
| Q2 24 | $302.6M | $130.4M | ||
| Q1 24 | $251.4M | $22.6M |
总债务ICUILCII
| Q4 25 | — | $945.2M | ||
| Q3 25 | — | $947.8M | ||
| Q2 25 | — | $948.0M | ||
| Q1 25 | — | $938.3M | ||
| Q4 24 | — | $757.3M | ||
| Q3 24 | — | $822.5M | ||
| Q2 24 | — | $829.7M | ||
| Q1 24 | — | $855.3M |
股东权益ICUILCII
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $2.1B | $1.4B | ||
| Q1 25 | $2.0B | $1.4B | ||
| Q4 24 | $2.0B | $1.4B | ||
| Q3 24 | $2.0B | $1.4B | ||
| Q2 24 | $2.0B | $1.4B | ||
| Q1 24 | $2.1B | $1.4B |
总资产ICUILCII
| Q4 25 | $4.1B | $3.2B | ||
| Q3 25 | $4.1B | $3.2B | ||
| Q2 25 | $4.1B | $3.2B | ||
| Q1 25 | $4.2B | $3.1B | ||
| Q4 24 | $4.2B | $2.9B | ||
| Q3 24 | $4.3B | $3.0B | ||
| Q2 24 | $4.3B | $3.0B | ||
| Q1 24 | $4.3B | $3.0B |
负债/权益比ICUILCII
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.70× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.55× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.60× | ||
| Q1 24 | — | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $78.9M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $64.3M |
| 自由现金流率自由现金流/营收 | 6.6% | 6.9% |
| 资本支出强度资本支出/营收 | 4.6% | 1.6% |
| 现金转化率经营现金流/净利润 | — | 4.22× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $278.3M |
8季度趋势，按日历期对齐
经营现金流ICUILCII
| Q4 25 | $60.6M | $78.9M | ||
| Q3 25 | $56.7M | $97.2M | ||
| Q2 25 | $11.2M | $112.2M | ||
| Q1 25 | $51.3M | $42.7M | ||
| Q4 24 | $40.2M | $106.6M | ||
| Q3 24 | $36.1M | $78.4M | ||
| Q2 24 | $82.0M | $192.9M | ||
| Q1 24 | $45.8M | $-7.7M |
自由现金流ICUILCII
| Q4 25 | $36.0M | $64.3M | ||
| Q3 25 | $27.6M | $80.9M | ||
| Q2 25 | $-8.5M | $99.5M | ||
| Q1 25 | $36.7M | $33.7M | ||
| Q4 24 | $16.1M | $95.7M | ||
| Q3 24 | $16.2M | $68.3M | ||
| Q2 24 | $62.5M | $180.2M | ||
| Q1 24 | $29.9M | $-16.3M |
自由现金流率ICUILCII
| Q4 25 | 6.6% | 6.9% | ||
| Q3 25 | 5.1% | 7.8% | ||
| Q2 25 | -1.5% | 9.0% | ||
| Q1 25 | 6.1% | 3.2% | ||
| Q4 24 | 2.6% | 11.9% | ||
| Q3 24 | 2.7% | 7.5% | ||
| Q2 24 | 10.5% | 17.1% | ||
| Q1 24 | 5.3% | -1.7% |
资本支出强度ICUILCII
| Q4 25 | 4.6% | 1.6% | ||
| Q3 25 | 5.4% | 1.6% | ||
| Q2 25 | 3.6% | 1.2% | ||
| Q1 25 | 2.4% | 0.9% | ||
| Q4 24 | 3.8% | 1.4% | ||
| Q3 24 | 3.4% | 1.1% | ||
| Q2 24 | 3.3% | 1.2% | ||
| Q1 24 | 2.8% | 0.9% |
现金转化率ICUILCII
| Q4 25 | — | 4.22× | ||
| Q3 25 | — | 1.55× | ||
| Q2 25 | 0.32× | 1.95× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 11.17× | ||
| Q3 24 | — | 2.20× | ||
| Q2 24 | — | 3.15× | ||
| Q1 24 | — | -0.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
LCII
| Travel Trailer And Fifth Wheels | $378.4M | 41% |
| Chassis Chassis Partsand Slideout Mechanisms | $206.1M | 22% |
| Furnitureand Mattresses | $120.4M | 13% |
| Appliances | $69.9M | 7% |
| Other Products | $69.1M | 7% |
| Axlesand Suspension Solutions | $62.3M | 7% |
| Motorhomes | $34.2M | 4% |
